The System Isn’t Working for Americans with Kidney Disease
September 05, 2024

Today, nearly 37 million Americans have chronic kidney disease (CKD), yet only about one percent of those Americans are even aware of their disease. And access to care is under threat.

Finerenone Improves Outcomes in Patients with Heart Failure and Mildly Reduced or Preserved Ejection Fraction
September 04, 2024

ESC 2024: Findings from the FINEARTS-HF clinical trial provide the first definite evidence that an MRA can be beneficial in patients with HFmrEF/HFpEF.

Regular Aspirin Use for CRC Prevention Found to Benefit Unhealthy Adults Most: Daily Dose
September 04, 2024

Your daily dose of the clinical news you may have missed.

FDA Grants Emergency Use Authorization for Updated Novavax COVID-19 Vaccine
September 03, 2024

The updated COVID-19 vaccine targets the currently circulating Omicron variant JN.1 strain of SARS-CoV-2.

Tirzepatide Reduces Risk for Progression from Prediabetes to T2D: Daily Dose
September 03, 2024

Your daily dose of the clinical news you may have missed.

The CRF Pathway Interrupted: Potential to Transform CAH Care
September 03, 2024

A therapeutic strategy that reduces ACTH-driven androgen excess through a glucocorticoid-independent pathway could significantly improve treatment and patient QoL.

Recreational Drug Users Face Triple the Risk of Repeat Major Adverse CV Events vs Non-Users
August 30, 2024

ESC 2024: Cannabis, opioid, and MDMA use were most strongly tied to cardiovascular event risk, according to a new study.

Geography May Matter in Dementia Diagnosis: Daily Dose
August 30, 2024

Your daily dose of the clinical news you may have missed.

PTSD and Risk of Poor T2D Outcomes in Veterans: Daily Dose
August 29, 2024

Your daily dose of the clinical news you may have missed.

T2D, Prediabetes Accelerate Brain Aging, but Healthier Lifestyle May Counteract the Association
August 29, 2024

Type 2 diabetes and prediabetes were associated with accelerated brain aging, particularly among men and persons with poor cardiometabolic health, according to new research.